India should prepare for the worst with Omicron
The World Health Organization said the number of COVID-19 cases recorded globally shot up by 11% last week (December 20-26) compared with the previous week, while the number of new…
Category: South Africa
Criticised if delayed in sharing data, punished for diligently posting data
After the first infection by a new variant — it has 32 mutations in the spike protein alone — was confirmed from a specimen collected on November 9, Botswana and…
mRNA vaccine manufacturers loathe to share know-how
In contrast, 54% of the total population in the U.S. is fully vaccinated. After approving booster shots for the immunocompromised people, on September 22, the U.S. FDA greenlighted booster shots…
Reneging on the ‘no-profit pledge’ to supply Oxford vaccine
On the say day the release was sent out announcing the partnership with AstraZeneca, Oxford University also tweeted saying that the vaccine will be manufactured and distributed “on a not-for-profit basis…
Editorial: An ominous situation
That the medicine chest is bereft of effective new drugs to fight the extremely drug-resistant tuberculosis (XDR-TB) strain has once again become frighteningly clear. According to a study published recently…
‘Long-term outcomes in South African patients with XDR-TB poor’
Long-term outcomes in South African patients who have extremely-drug resistant tuberculosis (XDR-TB) are “poor” immaterial of HIV status, notes a paper published on January 17 in The Lancet . Despite…
‘Nuances of childhood TB are never taught in medical schools’
If diagnosing tuberculosis in children, particularly those aged under five years, is fraught with problems, health-care workers at different levels who are unaware of the latest advancements in childhood TB…
Second-line TB drugs: ‘It is more difficult to assess adverse effects in children’
Prof. H. Simon Schaaf, a clinical researcher from the Department of Paediatrics and Child Health, Faculty of Health Sciences, Desmond Tutu TB Centre, Stellenbosch University, South Africa has worked…
Science Chronicle 